Literature DB >> 16264859

Importance of local control in an era of systemic therapy.

Samuel Hellman1, Ralph R Weichselbaum.   

Abstract

Mesh：

Year:  2005        PMID： 16264859     DOI： 10.1038/ncponc0075

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


× No keyword cloud information.
  15 in total

1.  New possibilities and potential benefits for local control in locally recurrent pancreatic cancer.

Authors:  Shane Lloyd; Bryan W Chang
Journal:  J Gastrointest Oncol       Date:  2013-12

2.  Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model.

Authors:  Barbara Diletto; Nicola Dinapoli; Silvia Chiesa; Gian Carlo Mattiucci; Vincenzo Frascino; Carmelo Anile; Cesare Colosimo; Vincenzo Valentini; Mario Balducci
Journal:  Med Oncol       Date:  2018-09-14       Impact factor: 3.064

3.  Treatment outcome for patients with primary NSCLC and synchronous solitary metastasis.

Authors:  Q Xu; Y Wang; H Liu; S Meng; S Zhou; J Xu; G Schmid-Bindert; C Zhou
Journal:  Clin Transl Oncol       Date:  2013-02-22       Impact factor: 3.405

4.  Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.

Authors:  Kathrin Dellas
Journal:  Breast Care (Basel)       Date:  2011-10-13       Impact factor: 2.860

5.  Prognostic analysis and beneficiary identification of adjuvant external beam radiotherapy for stage pT4b sigmoid colon cancer.

Authors:  Yaobin Lin; Lei Wang; Lingdong Shao; Xueqing Zhang; Huaqin Lin; Youjia Wang; Junxin Wu
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

6.  Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.

Authors:  Anand Mahadevan; Oliver Blanck; Rachelle Lanciano; Anuj Peddada; Srinath Sundararaman; David D'Ambrosio; Sanjeev Sharma; David Perry; James Kolker; Joanne Davis
Journal:  Radiat Oncol       Date:  2018-02-13       Impact factor: 3.481

Review 7.  Therapeutic Concepts for Oligometastatic Gastrointestinal Tumours.

Authors:  Jens Ricke; Christoph Benedikt Westphalen; Max Seidensticker
Journal:  Visc Med       Date:  2020-10-05

8.  Stereotactic body radiotherapy for metachronous multisite oligo-recurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature.

Authors:  Hiroshi Onishi; Masatoki Ozaki; Kengo Kuriyama; Takafumi Komiyama; Kan Marino; Masayuki Araya; Ryo Saito; Shinichi Aoki; Yoshiyasu Maehata; Licht Tominaga; Mitsuhiko Oguri; Iori Watanabe; Kojiro Onohara; Meguru Watanabe; Naoki Sano; Tsutomu Araki
Journal:  Pulm Med       Date:  2012-10-23

9.  A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer.

Authors:  Pretesh R Patel; David S Yoo; Yuzuru Niibe; James J Urbanic; Joseph K Salama
Journal:  Pulm Med       Date:  2012-10-17

Review 10.  Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options.

Authors:  Antonio José Conde Moreno; Carlos Ferrer Albiach; Rodrigo Muelas Soria; Verónica González Vidal; Raquel García Gómez; María Albert Antequera
Journal:  Radiat Oncol       Date:  2014-12-11       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.